WHO pushes for new malaria, TB and HIV vaccines to benefit Kenya
|
The study confirms the need to focus on vaccine
development for longstanding health threats like HIV, malaria, and
tuberculosis. Together, these three ... |
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in ...
Many guidelines recommend baseline drug resistance testing prior to antiretroviral therapy (ART) initiation, that may not always be readily accessible ... View article...